161404-01-9

Upstream product

• 147-85-3 L-proline 
• 161404-00-8 Z-Pro-Phe-Pro-Gly-EtDA<*>Gly<*>Gly-Boc 
• 161403-98-1 Z-Phe-Pro-Gly-EtDa<*>Gly<*>Gly-Boc 
• 161403-99-2 [({[2-(2-{[(S)-1-((S)-2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-acetylamino)-ethylcarbamoyl]-methyl}-carbamoyl)-methyl]-carbamic acid tert-butyl ester 
• 161403-97-0 Z-Gly-EtDA<*>Gly-Gly-Boc 
• 161403-91-4 Z-Gly-EtDA<*>Gly-Boc 
• 7669-64-9 (2S)-1-((2S)-2-[[(benzyloxy)carbonyl]amino]-3-phenylpropanoyl)tetrahydro-1H-pyrrole-2-carboxylic acid 
• 2578-84-9 N-benzyloxycarbonyl-L-phenylalanine p-nitrophenyl ester 
• 3655-05-8 tert-butoxycarbonylglycine p-nitrophenylester 

Downstream Products

• 132370-20-8 H-Tyr-Pro-Phe-Pro-Gly-EtDA<*>Gly<*>Gly-H 
• 161404-03-1 Z-Tyr(Bzl)-Pro-Phe-Pro-Gly-EtDA<*>Gly<*>Gly-CO-(CH2)2-COOH 

Relevant academic research and scientific papers

SYNTHESIS AND BIOLOGICAL ACTIVITIES OF NEW ANALOGUES OF β-CASOMORPHINE-5*

Four new analogues of β-casomorphine-5 modified at the C-end by modifiers based on ethylenediamine and glycine residues have been synthesized. the opioid and analgesic activities of the peptides obtained comparison with β-casomorphine-5 and morphine are discussed.